LifeBank Chain (LBC) focuses on genetics and cell research, with the purposes of furthering human longevity and expanding access to genetics and cell treatments. JERUSALEM, Jan. 12, 2022 (GLOBE NEWSWIRE) — Recently, a start-up project “LifeBank Chain (LBC)” in Israel is utilizing advanced gene and cell technologies over blockchain to develop advanced therapies. They endeavor […]
Day: January 12, 2022
Jitterbit Acquires Low-Code Dev Innovator PrimeApps to Give Organizations a Radically New Way to Build Business Apps
End-to-End Platform Empowers Businesses to Create Secure and Scalable Digital Experiences, Slashing Costs and Development Time from Months to Days ALAMEDA, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) — Jitterbit, the API transformation company, today announced it has acquired PrimeApps, a Turkey-based innovator in low-code application development. By combining Jitterbit’s API integrator with PrimeApps, the company will offer […]
Schneider Electric achieves outstanding performance in four corporate sustainability ratings
Strong and consistent performance running for over a decade ESG recognition in line with company’s sustainable business growth ambitions Rueil-Malmaison (France), January 12, 2022 – Schneider Electric, the leader in the digital transformation of energy management and automation, has delivered yet another strong year of Environmental, Social and Governance (ESG) performance based on 2021 ratings […]
President: The Lachin corridor is under our control, we can stop any car there and no-one can tell us anything
In assessing the work of peacekeepers, I think we need to look at it from a broader perspective, and, of course, there are many sources of concern. At the same time, it would be unfair not to mention their positive function. They are performing an important function now. At the same time, they accompany the […]
Turkish scientist developed medicine for lung cancer
Boğaziçi University Faculty Member Prof. Dr. Rana Nomak Sanyal and her team started the clinical stages of the drug they developed for lung cancer. Phase-1 studies of the drug, which was developed for patients with recurrent, metastatic or advanced lung cancer, started at Ankara Oncology Training and Research Hospital Phase-1 Clinical Research Center. In the […]